title: Markers of nonselective and specific NK cell activation.
abstract: NK cell activation is controlled by the integration of signals from cytokine receptors and germline-encoded activation and inhibitory receptors. NK cells undergo two distinct phases of activation during murine CMV (MCMV) infection: a nonselective phase mediated by proinflammatory cytokines and a specific phase driven by signaling through Ly49H, an NK cell activation receptor that recognizes infected cells. We sought to delineate cell surface markers that could distinguish NK cells that had been activated nonselectively from those that had been specifically activated through NK cell receptors. We demonstrated that stem cell Ag 1 (Sca-1) is highly upregulated during viral infections (to an even greater extent than CD69) and serves as a novel marker of early, nonselective NK cell activation. Indeed, a greater proportion of Sca-1(+) NK cells produced IFN-γ compared with Sca-1(-) NK cells during MCMV infection. In contrast to the universal upregulation of Sca-1 (as well as KLRG1) on NK cells early during MCMV infection, differential expression of Sca-1, as well as CD27 and KLRG1, was observed on Ly49H(+) and Ly49H(-) NK cells late during MCMV infection. Persistently elevated levels of KLRG1 in the context of downregulation of Sca-1 and CD27 were observed on NK cells that expressed Ly49H. Furthermore, the differential expression patterns of these cell surface markers were dependent on Ly49H recognition of its ligand and did not occur solely as a result of cellular proliferation. These findings demonstrate that a combination of Sca-1, CD27, and KLRG1 can distinguish NK cells nonselectively activated by cytokines from those specifically stimulated through activation receptors.
authors: Division of Pediatric Rheumatology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
authors: Leslie A
authors: LA
authors: Fogel
authors: Michel M
authors: MM
authors: Sun
authors: Theresa L
authors: TL
authors: Geurs
authors: Leonidas N
authors: LN
authors: Carayannopoulos
authors: Anthony R
authors: AR
authors: French
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000032:analysis* / Q000378:metabolism; D005434:Flow Cytometry; D007694:Killer Cells, Natural / Q000276:immunology* / Q000378:metabolism; D008213:Lymphocyte Activation / Q000276:immunology*; D008565:Membrane Proteins / Q000276:immunology* / Q000378:metabolism; D051379:Mice; D060888:Real-Time Polymerase Chain Reaction
chemical_list: D015415:Biomarkers; D008565:Membrane Proteins
references: J Immunol. 1990 Mar 15;144(6):2197-204
references: 2107254
references: J Virol. 2005 Sep;79(18):12112-6
references: 16140789
references: J Immunol. 1991 Aug 15;147(4):1171-9
references: 1907991
references: Eur J Immunol. 2005 Apr;35(4):1113-23
references: 15756645
references: J Exp Med. 2011 Feb 14;208(2):357-68
references: 21262959
references: Blood. 2008 Aug 1;112(3):914-5
references: 18650467
references: PLoS Pathog. 2008 Feb 8;4(2):e30
references: 18266471
references: J Immunol. 1983 Sep;131(3):1531-8
references: 6309965
references: J Exp Med. 2011 Jan 17;208(1):13-21
references: 21173105
references: Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14725-32
references: 21825173
references: Cell. 1992 Jan 10;68(1):83-95
references: 1531041
references: Immunity. 2011 Apr 22;34(4):579-89
references: 21439856
references: J Exp Med. 1997 Aug 29;186(5):705-17
references: 9271586
references: J Immunol. 1987 Jan 1;138(1):91-7
references: 3023490
references: Nat Rev Mol Cell Biol. 2010 Oct;11(10):688-99
references: 20861879
references: Exp Hematol. 2005 Jul;33(7):836-43
references: 15963860
references: Immunity. 2004 Jul;21(1):107-19
references: 15345224
references: Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8826-31
references: 12060703
references: J Exp Med. 1986 Sep 1;164(3):709-22
references: 3489060
references: Nat Immunol. 2001 Oct;2(10):951-6
references: 11550009
references: Science. 2001 May 4;292(5518):934-7
references: 11340207
references: Mol Cell Biol. 1990 Oct;10(10):5150-9
references: 1697928
references: J Exp Med. 2001 Jul 2;194(1):29-44
references: 11435470
references: J Immunol. 2009 Nov 1;183(9):5830-6
references: 19828630
references: Eur J Immunol. 2002 Jun;32(6):1584-92
references: 12115641
references: Arch Immunol Ther Exp (Warsz). 2004 Jul-Aug;52(4):255-66
references: 15467490
references: N Engl J Med. 1989 Jun 29;320(26):1731-5
references: 2543925
references: Immunogenetics. 2008 Oct;60(10):565-73
references: 18668236
references: Immunity. 2004 Jun;20(6):747-56
references: 15189739
references: Immunol Rev. 2006 Dec;214:47-55
references: 17100875
references: Eur Cytokine Netw. 1999 Mar;10(1):49-56
references: 10210773
references: Nat Immunol. 2006 May;7(5):517-23
references: 16565719
references: J Immunol. 1974 May;112(5):1774-81
references: 4131875
references: J Autoimmun. 2012 May;38(2-3):J245-53
references: 22209097
references: J Immunol. 2012 Apr 1;188(7):2981-90
references: 22379026
references: J Immunol. 2002 Jan 1;168(1):118-26
references: 11751954
references: J Immunol. 2002 Nov 1;169(9):5130-6
references: 12391229
references: J Immunol. 2009 Sep 1;183(5):2911-4
references: 19648279
references: J Immunol. 1991 May 15;146(10):3662-73
references: 2026886
references: J Immunol. 2002 Mar 15;168(6):2585-9
references: 11884419
references: Eur J Immunol. 1987 Aug;17(8):1183-91
references: 3040423
references: J Exp Med. 1993 Aug 1;178(2):537-47
references: 8340758
references: Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6806-10
references: 7688129
references: J Immunol. 2004 Jul 1;173(1):259-66
references: 15210783
references: J Exp Med. 2011 May 9;208(5):1105-17
references: 21518798
references: Nat Genet. 2001 May;28(1):42-5
references: 11326273
references: J Immunol. 2007 Apr 15;178(8):4764-70
references: 17404256
references: Immunity. 2000 Sep;13(3):355-64
references: 11021533
references: Nat Immunol. 2008 Oct;9(10):1091-4
references: 18800157
references: Blood. 2001 Sep 1;98(5):1489-97
references: 11520799
references: Int J Cancer. 1991 May 30;48(3):473-5
references: 1904052
references: Nature. 2009 Jan 29;457(7229):557-61
references: 19136945
references: Exp Hematol. 2003 Feb;31(2):159-67
references: 12591281
references: Science. 2002 May 17;296(5571):1323-6
references: 11950999
references: EMBO J. 1986 Dec 1;5(12):3227-34
references: 3028776
references: Eur J Immunol. 1993 Sep;23(9):2257-62
references: 8103746
references: Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11284-8
references: 7479980
references: J Immunol. 2002 Oct 15;169(8):4279-87
references: 12370359
references: Eur J Immunol. 1998 Dec;28(12):4409-17
references: 9862378
references: J Immunol. 2006 Oct 15;177(8):4981-90
references: 17015680
references: Eur J Immunol. 1993 Apr;23(4):825-31
references: 8096181
references: Cell Immunol. 2003 Sep;225(1):42-52
references: 14643303
references: Annu Rev Immunol. 2004;22:405-29
references: 15032583
references: J Virol Methods. 2006 Feb;131(2):122-9
references: 16140399
references: J Exp Med. 2003 Feb 17;197(4):515-26
references: 12591908
references: J Immunol. 1998 Dec 15;161(12):6451-4
references: 9862665
references: J Exp Med. 2003 May 5;197(9):1093-106
references: 12732655
references: J Exp Med. 1988 May 1;167(5):1572-85
references: 3259252
references: J Virol. 2004 Jul;78(14):7536-44
references: 15220428